Evolus, Inc. (EOLS)
Evolus Market Cap : 443.81M for Nov. 17, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 438.52M |
| November 13, 2026 | 460.35M |
| November 12, 2026 | 474.90M |
| November 11, 2026 | 490.77M |
| November 10, 2026 | 450.43M |
| November 09, 2026 | 461.67M |
| November 06, 2026 | 450.10M |
| November 05, 2026 | 449.44M |
| November 04, 2026 | 494.08M |
| November 03, 2026 | 487.47M |
| November 02, 2026 | 472.66M |
| October 30, 2026 | 485.20M |
| October 29, 2026 | 496.42M |
| October 28, 2026 | 504.01M |
| October 27, 2026 | 486.52M |
| October 26, 2026 | 473.32M |
| October 23, 2026 | 462.76M |
| October 22, 2026 | 489.16M |
| October 21, 2026 | 488.50M |
| October 20, 2026 | 486.52M |
| October 19, 2026 | 485.86M |
| October 16, 2026 | 468.70M |
| October 15, 2026 | 499.72M |
| October 14, 2026 | 476.62M |
| October 13, 2026 | 495.76M |
| Date | Value |
|---|---|
| October 12, 2026 | 511.61M |
| October 09, 2026 | 510.29M |
| October 08, 2026 | 514.91M |
| October 07, 2026 | 510.95M |
| October 06, 2026 | 487.18M |
| October 05, 2026 | 493.12M |
| October 02, 2026 | 471.34M |
| October 01, 2026 | 507.65M |
| September 30, 2026 | 528.11M |
| September 29, 2026 | 527.45M |
| September 28, 2026 | 525.47M |
| September 25, 2026 | 526.13M |
| September 24, 2026 | 518.87M |
| September 23, 2026 | 528.11M |
| September 22, 2026 | 544.61M |
| September 21, 2026 | 527.45M |
| September 18, 2026 | 518.87M |
| September 17, 2026 | 528.77M |
| September 16, 2026 | 527.45M |
| September 15, 2026 | 522.17M |
| September 14, 2026 | 523.49M |
| September 11, 2026 | 517.55M |
| September 10, 2026 | 522.17M |
| September 09, 2026 | 565.74M |
| September 08, 2026 | 586.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.603B |
| Corcept Therapeutics, Inc. | 7.657B |
| Veru, Inc. | 36.66M |
| Johnson & Johnson | 671.59B |
| Eli Lilly & Co. | 1.327T |
Market Cap Related Metrics
| PS Ratio | 1.353 |
| Price | 6.71 |
| Earnings Yield | -7.05% |